Nutranomics, Inc. (OTC Pink: NNRX) is engaged as an alternative health and nutraceutical product development company. Shares of the alternative health company skyrocketed 125% during trading on Tuesday, October 30, 2018. Over the past month, Nutranomics, Inc. has seen average daily volume of 4.31 million shares. However, volume of 234.25 million shares or dollar volume of $210,825, exchanged hands during Tuesday’s trading.
Shares of Nutranomics soared on Tuesday, after the company announced plans to develop its own line of CBD-based products. The product line will go along with the company’s existing portfolio of nutraceutical products. Management is currently seeking strategic partnerships to help bring its CBD product to market. Here is the full press release detailing of the CBD product plans:
Nutranomics, Inc. Press Release:
Salt Lake City, UT, Oct. 30, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — NutraNomics, Inc. formerly DBA Health Education Corp. (NNRX) announced today the Company’s plans to begin development on a new line of CBD products to add to their already successful, existing line of nutraceutical offerings. The Company stated that after reviewing and numerous successful laboratory study results, the Company is currently seeking strategic partnerships to source raw materials and begin the process of developing, manufacturing and bringing a high-quality CBD product to market. Current CBD research has shown tremendous success in dealing with anxiety reduction, depression, heart health, athletic recovery, diabetes prevention as well as assisting in the recovery process for various illnesses and injuries including cancer. NutraNomics will continue to sell and promote its products through multiple distribution, manufacturing and marketing agreements it has successfully reached, thereby continuing its rapid growth.
NutraNomics has secured its place as a leading innovator in its field of nutraceuticals. New and improved proprietary formulas focused on even quicker and more effective absorption rates will boost us as an industry leader in the fight against personal health setbacks like neuropathy, pre-diabetic disorders, and migraine headaches, with an emphasis on improving blood flow. Our most popular products to date still include: Amazon Factor, Super DTX, Essential Vite and Calming Aid, all of which work to bring balance to the body and support healing.
“This is a particularly exciting time for the Company. We have been working diligently and tirelessly to redefine the Company and position it for the growth it is now experiencing,” explains CEO and President, Jonathan Bishop. “We’ve made significant advancements in product agreements and services and are very enthusiastic about our future.”
Safe Harbor Statement
This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results or implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company’s control. Forward-looking statements speak only as to the date they are made and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
